NHS England publishes clinical commissioning policy on adalimumab for children with uveitis
NHS England has today published an interim clinical commissioning policy on the use of adalimumab for children with severe refractory uveitis, recommending its use for patients who meet the clinical criteria it sets out. This policy will benefit children for whom uveitis threatens their sight, and for whom other treatments have proven ineffective. A policy […]